CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 155.16 Million EUR | -9.72% |
| 2022 | 125.61 Million EUR | 15.57% |
| 2021 | 108.68 Million EUR | -9.18% |
| 2020 | 119.67 Million EUR | 6.58% |
| 2019 | 112.28 Million EUR | -17.76% |
| 2018 | 136.53 Million EUR | 63.72% |
| 2017 | 83.39 Million EUR | 9.23% |
| 2016 | 76.34 Million EUR | 18.63% |
| 2015 | 64.35 Million EUR | 50.11% |
| 2014 | 42.87 Million EUR | -24.56% |
| 2013 | 56.82 Million EUR | -12.91% |
| 2012 | 65.25 Million EUR | 78.02% |
| 2011 | 36.65 Million EUR | 10.86% |
| 2010 | 33.06 Million EUR | 33.34% |
| 2009 | 24.79 Million EUR | 93.72% |
| 2008 | 12.8 Million EUR | -53.35% |
| 2007 | 27.43 Million EUR | 25.21% |
| 2006 | 21.91 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 34.2 Million EUR | 1723.26% |
| 2024 Q2 | 26.71 Million EUR | 153.66% |
| 2023 Q1 | 29.33 Million EUR | -1.71% |
| 2023 FY | 113.39 Million EUR | -9.72% |
| 2023 Q4 | -2.1 Million EUR | -106.36% |
| 2023 Q3 | 33.12 Million EUR | -35.91% |
| 2023 Q2 | 51.68 Million EUR | 76.19% |
| 2022 Q2 | 20.19 Million EUR | -29.32% |
| 2022 Q3 | 46.99 Million EUR | 132.64% |
| 2022 Q1 | 28.58 Million EUR | 56.27% |
| 2022 FY | 125.61 Million EUR | 15.57% |
| 2022 Q4 | 29.84 Million EUR | -36.49% |
| 2021 Q2 | 21.82 Million EUR | 36.11% |
| 2021 Q3 | 41.83 Million EUR | 91.73% |
| 2021 Q4 | 18.28 Million EUR | -56.29% |
| 2021 FY | 108.68 Million EUR | -9.18% |
| 2021 Q1 | 16.03 Million EUR | -46.35% |
| 2020 FY | 119.67 Million EUR | 6.58% |
| 2020 Q4 | 29.88 Million EUR | -35.75% |
| 2020 Q3 | 46.51 Million EUR | 101.45% |
| 2020 Q2 | 23.08 Million EUR | 2.72% |
| 2020 Q1 | 22.47 Million EUR | -37.48% |
| 2019 Q1 | 30.39 Million EUR | -24.71% |
| 2019 Q3 | 28.48 Million EUR | 32.26% |
| 2019 Q4 | 35.95 Million EUR | 26.2% |
| 2019 Q2 | 21.54 Million EUR | -29.12% |
| 2019 FY | 112.28 Million EUR | -17.76% |
| 2018 Q1 | 26.7 Million EUR | -1.33% |
| 2018 Q4 | 40.36 Million EUR | 51.35% |
| 2018 Q3 | 26.67 Million EUR | -37.68% |
| 2018 Q2 | 42.79 Million EUR | 60.26% |
| 2018 FY | 136.53 Million EUR | 63.72% |
| 2017 Q2 | 18.99 Million EUR | 0.05% |
| 2017 FY | 83.39 Million EUR | 9.23% |
| 2017 Q4 | 27.06 Million EUR | 32.07% |
| 2017 Q3 | 20.49 Million EUR | 7.9% |
| 2017 Q1 | 18.98 Million EUR | -23.02% |
| 2016 Q2 | 15.58 Million EUR | -19.38% |
| 2016 Q4 | 24.65 Million EUR | 47.03% |
| 2016 FY | 76.34 Million EUR | 18.63% |
| 2016 Q3 | 16.77 Million EUR | 7.59% |
| 2016 Q1 | 19.33 Million EUR | 5.23% |
| 2015 Q2 | 18.28 Million EUR | 4.28% |
| 2015 Q3 | 10.15 Million EUR | -44.46% |
| 2015 FY | 64.35 Million EUR | 50.11% |
| 2015 Q1 | 17.53 Million EUR | 151.99% |
| 2015 Q4 | 18.37 Million EUR | 80.89% |
| 2014 Q1 | 11.7 Million EUR | -79.39% |
| 2014 Q4 | 6.95 Million EUR | -40.78% |
| 2014 FY | 42.87 Million EUR | -24.56% |
| 2014 Q2 | 12.45 Million EUR | 6.46% |
| 2014 Q3 | 11.75 Million EUR | -5.68% |
| 2013 FY | 56.82 Million EUR | -12.91% |
| 2013 Q4 | 56.78 Million EUR | 271.55% |
| 2013 Q1 | 14.92 Million EUR | -66.56% |
| 2013 Q3 | 15.28 Million EUR | 72.8% |
| 2013 Q2 | 8.84 Million EUR | -40.75% |
| 2012 Q2 | 15.83 Million EUR | -6.7% |
| 2012 Q1 | 16.96 Million EUR | 8.06% |
| 2012 Q3 | 14.8 Million EUR | -6.49% |
| 2012 Q4 | 44.65 Million EUR | 201.61% |
| 2012 FY | 65.25 Million EUR | 78.02% |
| 2011 Q2 | 2.61 Million EUR | -43.64% |
| 2011 Q4 | 15.7 Million EUR | 14.53% |
| 2011 FY | 36.65 Million EUR | 10.86% |
| 2011 Q3 | 13.71 Million EUR | 425.33% |
| 2011 Q1 | 4.63 Million EUR | -60.16% |
| 2010 Q2 | 7.57 Million EUR | 65.65% |
| 2010 FY | 33.06 Million EUR | 33.34% |
| 2010 Q1 | 4.57 Million EUR | -37.2% |
| 2010 Q4 | 11.62 Million EUR | 25.15% |
| 2010 Q3 | 9.28 Million EUR | 22.58% |
| 2009 Q3 | 8.06 Million EUR | 55.85% |
| 2009 FY | 24.79 Million EUR | 93.72% |
| 2009 Q1 | 4.27 Million EUR | 0.0% |
| 2009 Q4 | 7.28 Million EUR | -9.72% |
| 2009 Q2 | 5.17 Million EUR | 21.19% |
| 2008 FY | 12.8 Million EUR | -53.35% |
| 2007 FY | 27.43 Million EUR | 25.21% |
| 2006 FY | 21.91 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DocCheck AG | 3.54 Million EUR | -4279.956% |
| MeVis Medical Solutions AG | 6.44 Million EUR | -2307.926% |
| Nexus AG | 24.76 Million EUR | -526.508% |